Valuation: Dermapharm Holding SE

Market Cap 2.06B 2.35B 1.91B 1.76B 3.31B 226B 3.35B 22.79B 8.92B 111B 8.83B 8.64B 383B P/E 2026 *
15.7x
P/E 2027 * 14.2x
Enterprise Value 2.85B 3.25B 2.64B 2.43B 4.59B 313B 4.64B 31.55B 12.35B 154B 12.22B 11.96B 530B EV / Sales 2026 *
2.36x
EV / Sales 2027 * 2.15x
Free-Float
10.7%
Yield 2026 *
2.44%
Yield 2027 * 2.7%
1 day-3.55%
1 week-7.59%
Current month-14.74%
1 month-13.64%
3 months-12.13%
6 months+11.05%
Current year+2.16%
1 week 40.1
Extreme 40.1
43.95
1 month 40.1
Extreme 40.1
48.1
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 2017-07-31
Director of Finance/CFO - 2022-10-31
Investor Relations Contact - 2018-11-30
Director TitleAgeSince
Chairman 70 2017-07-31
Director/Board Member 66 2017-07-31
Director/Board Member 77 2017-12-31
Date Insider Type Main position Quantity % Market Cap.
5/14/26 Buy

Chairman

380,000 0.7670%
1/7/26 Buy 150 0.0003%
1/7/26 Buy 2,050 0.0038%
Change 5-day change 1-year change 3-year change Capi.($)
-3.55%-7.59%+18.58%-6.60% 2.35B
-0.72%+0.54%+49.76%+153.16% 1,048B
+2.02%+3.10%+51.65%+48.86% 603B
+0.18%+4.91%+36.87%+78.86% 452B
-0.09%+1.06%+31.33%+22.01% 327B
-0.37%+2.61%+35.84%+37.86% 283B
+1.71%+1.15%+22.78%+17.90% 259B
-1.40%-3.34%-24.63%-41.91% 219B
+0.36%+2.47%+20.12%+55.97% 198B
+0.87%-0.35%+19.13%+69.00% 162B
Average -0.11%+1.17%+26.14%+43.51% 355.41B
Weighted average by Cap. +0.17%+1.69%+36.03%+73.52%

Financials

2026 *2027 *
Net sales 1.21B 1.38B 1.12B 1.03B 1.94B 133B 1.97B 13.37B 5.23B 65.08B 5.18B 5.06B 225B 1.25B 1.43B 1.16B 1.07B 2.02B 138B 2.04B 13.87B 5.43B 67.55B 5.37B 5.26B 233B
Net income 139M 159M 129M 119M 224M 15.27B 226M 1.54B 602M 7.49B 595M 582M 25.84B 155M 177M 144M 132M 250M 17.05B 253M 1.72B 671M 8.36B 665M 650M 28.85B
Net Debt 792M 904M 734M 676M 1.27B 87.03B 1.29B 8.76B 3.43B 42.65B 3.39B 3.32B 147B 636M 725M 589M 542M 1.02B 69.83B 1.03B 7.03B 2.75B 34.22B 2.72B 2.66B 118B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,503
Date Price Change Volume
26-07-22 40.25 -3.25% 15,409
26-07-21 €41.60 -1.42% 19,188
26-07-20 €42.20 -2.31% 19,474
26-07-17 €43.20 -1.03% 58,811
26-07-16 €43.65 +0.34% 13,544
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
41.60EUR
Average target price
50.38EUR
Spread / Average Target
+21.09%

Quarterly revenue - Rate of surprise